News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
196,334 Results
Type
Article (9319)
Company Profile (38)
Press Release (186977)
Multimedia
Podcasts (5)
Webinars (4)
Section
Business (64911)
Career Advice (273)
Deals (12557)
Drug Delivery (23)
Drug Development (24759)
Employer Resources (69)
FDA (4618)
Job Trends (5205)
News (105024)
Policy (7874)
Tag
Academia (654)
Accelerated approval (1)
Adcomms (3)
Allergies (35)
Alliances (9466)
ALS (22)
Alzheimer's disease (426)
Antibody-drug conjugate (ADC) (35)
Approvals (4664)
Artificial intelligence (47)
Autoimmune disease (5)
Automation (3)
Bankruptcy (77)
Best Places to Work (4432)
BIOSECURE Act (2)
Biosimilars (26)
Biotechnology (25)
Bladder cancer (36)
Brain cancer (12)
Breast cancer (107)
Cancer (869)
Cardiovascular disease (72)
Career advice (224)
Career pathing (6)
CAR-T (34)
Cell therapy (119)
Cervical cancer (4)
Clinical research (21072)
Collaboration (183)
Compensation (413)
Complete response letters (1)
COVID-19 (788)
CRISPR (10)
C-suite (94)
Cystic fibrosis (32)
Data (990)
Denatured (1)
Depression (12)
Diabetes (90)
Diagnostics (1971)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (16)
Drug discovery (31)
Drug pricing (30)
Drug shortages (8)
Duchenne muscular dystrophy (35)
Earnings (40464)
Editorial (8)
Employer branding (6)
Employer resources (56)
Events (28374)
Executive appointments (242)
FDA (5089)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (215)
Gene editing (26)
Generative AI (4)
Gene therapy (99)
GLP-1 (260)
Government (1122)
Grass and pollen (1)
Guidances (146)
Healthcare (6337)
Huntington's disease (3)
IgA nephropathy (16)
Immunology and inflammation (38)
Indications (13)
Infectious disease (827)
Inflammatory bowel disease (52)
Inflation Reduction Act (3)
Influenza (14)
Intellectual property (23)
Interviews (41)
IPO (7788)
IRA (5)
Job creations (969)
Job search strategy (202)
Kidney cancer (8)
Labor market (18)
Layoffs (158)
Leadership (2)
Legal (1498)
Liver cancer (20)
Lung cancer (137)
Lymphoma (74)
Machine learning (1)
Management (23)
Manufacturing (64)
MASH (26)
Medical device (4354)
Medtech (4354)
Mergers & acquisitions (4997)
Metabolic disorders (244)
Multiple sclerosis (32)
NASH (6)
Neurodegenerative disease (26)
Neuropsychiatric disorders (8)
Neuroscience (589)
NextGen: Class of 2025 (1684)
Non-profit (1246)
Now hiring (3)
Obesity (133)
Opinion (46)
Ovarian cancer (22)
Pain (21)
Pancreatic cancer (32)
Parkinson's disease (46)
Partnered (3)
Patents (49)
Patient recruitment (24)
Peanut (19)
People (14266)
Pharmaceutical (11)
Pharmacy benefit managers (2)
Phase I (5618)
Phase II (9143)
Phase III (8201)
Pipeline (900)
Policy (24)
Postmarket research (796)
Preclinical (1826)
Press Release (9)
Prostate cancer (30)
Psychedelics (5)
Radiopharmaceuticals (85)
Rare diseases (126)
Real estate (1286)
Recruiting (28)
Regulatory (5872)
Reports (19)
Research institute (646)
Resumes & cover letters (49)
Rett syndrome (2)
RNA editing (2)
RSV (9)
Schizophrenia (24)
Series A (33)
Series B (17)
Service/supplier (3)
Sickle cell disease (17)
Special edition (7)
Spinal muscular atrophy (74)
Sponsored (9)
Startups (847)
Stomach cancer (3)
Supply chain (15)
Tariffs (15)
The Weekly (4)
Vaccines (251)
Venture capitalists (11)
Weight loss (86)
Women's health (4)
Worklife (4)
Date
Today (124)
Last 7 days (490)
Last 30 days (1383)
Last 365 days (11286)
2025 (4556)
2024 (11742)
2023 (13116)
2022 (30246)
2021 (17359)
2020 (15477)
2019 (13181)
2018 (10058)
2017 (9135)
2016 (8061)
2015 (9863)
2014 (6841)
2013 (5295)
2012 (5455)
2011 (5872)
2010 (4981)
Location
Africa (181)
Alabama (36)
Alaska (1)
Arizona (49)
Arkansas (4)
Asia (11344)
Australia (1803)
California (2324)
Canada (738)
China (164)
Colorado (76)
Connecticut (87)
Delaware (76)
Europe (26483)
Florida (310)
Georgia (61)
Idaho (11)
Illinois (142)
India (11)
Indiana (157)
Iowa (2)
Japan (62)
Kansas (32)
Kentucky (6)
Louisiana (4)
Maine (23)
Maryland (298)
Massachusetts (1609)
Michigan (68)
Minnesota (98)
Mississippi (1)
Missouri (22)
Montana (9)
Nebraska (7)
Nevada (21)
New Hampshire (24)
New Jersey (652)
New Mexico (3)
New York (596)
North Carolina (323)
North Dakota (1)
Northern California (1100)
Ohio (38)
Oklahoma (2)
Oregon (3)
Pennsylvania (538)
Puerto Rico (3)
South America (288)
South Carolina (6)
Southern California (920)
Tennessee (47)
Texas (339)
United States (8227)
Utah (62)
Virginia (48)
Washington D.C. (11)
Washington State (191)
West Virginia (2)
Wisconsin (12)
196,334 Results for "25".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pipeline
JPM25 Day Two: Roche, Amgen, Merck, Lilly and Biogen
JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in the coming year.
January 15, 2025
·
4 min read
·
Tristan Manalac
Press Releases
InVitria Launches Optibumin® 25, the First Recombinant 25% Human Serum Albumin for Closed-System Biomanufacturing
April 30, 2025
·
1 min read
Press Releases
Collegium Announces $25 Million Accelerated Share Repurchase Program
May 12, 2025
·
5 min read
Press Releases
bioAffinity Technologies Announces Pricing of $3.25 Million Offering
May 7, 2025
·
4 min read
Press Releases
Coloplast A/S Revised guidance for FY 2024/25
May 1, 2025
·
3 min read
Press Releases
Immutep Quarterly Activities Report Q3 FY25
April 30, 2025
·
8 min read
Press Releases
TILT Biotherapeutics Announces Closing of USD 25 Million Series B Financing
May 13, 2025
·
4 min read
Press Releases
Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments
May 7, 2025
·
4 min read
Cancer
Merck, Boehringer Ingelheim, More To Present Key Data at AACR ’25
Presentations at this year’s American Association for Cancer Research meeting could have a broad impact on the treatment landscape for head and neck and lung cancer, and implications for specific drug modalities like TIGIT and VEGF.
April 25, 2025
·
4 min read
·
Tristan Manalac
Cancer
Perioperative Keytruda Cuts Risk of Negative Events by Over 25% in Head and Neck Cancer
The FDA is currently reviewing Merck’s sBLA for Keytruda in head and neck cancer, with a target action date of June 23.
April 28, 2025
·
1 min read
·
Tristan Manalac
1 of 19,634
Next
